Factors affecting medication discontinuation in patients with overactive bladder symptomsopen access
- Authors
- 김영미[김영미]; 김동욱[김동욱]; 심은정[심은정]; 유은희[유은희]
- Issue Date
- 2015
- Publisher
- 대한산부인과학회
- Keywords
- Discontinuation; Muscarinic antagonists; Urinary bladder; overactive
- Citation
- Obstetrics & Gynecology Science, v.58, no.6, pp.507 - 513
- Indexed
- KCI
- Journal Title
- Obstetrics & Gynecology Science
- Volume
- 58
- Number
- 6
- Start Page
- 507
- End Page
- 513
- URI
- https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/45728
- DOI
- 10.5468/ogs.2015.58.6.507
- ISSN
- 2287-8572
- Abstract
- Objective To find out the factors affecting medication discontinuation in patients with overactive bladder (OAB) symptoms.
Methods The clinical data of 125 patients with OAB symptoms who had taken antimuscarinics and behavioral therapy were retrospectivelyreviewed. Antimuscarinics related outcomes were evaluated by an independent observer with telephone interview. All patients were asked about duration of medication and reason of continuation or discontinuation of antimuscarinics.
To determine pre-treatment factors predicting self-report discontinuation of antimuscarinics, variables of only those with P-values <0.25 on the univariate analysis were included in the Cox proportional hazard modeling.
Results Mean follow-up was 39.6 months and the proportion of discontinuation of antimuscarinics was 60.0% (75/125). The mean duration of medication was 21.2 months in the continuation group and 3.3 months in the discontinuationgroup. The reasons of discontinuation of antimuscarinics were improved OAB symptoms (46.7%), tolerable OAB symptoms (33.3%), no change of OAB symptoms (1.3%), side-effects (8.0%) and no desire to take long-term medication(10.7%). The variables affecting remaining cumulative probability of antimuscarinics were age, history of anti-incontinence surgery or vaginal surgery, and having stress predominant urinary incontinence on urodynamic study.
Conclusion The lower rate of cumulative continuation of antimuscarinics encourages us to give a more detailed counseling and education to the patients with OAB symptoms before prescription. And explorations about newer agent and non-pharmacologic treatment with good efficacy and lower side-effects are needed.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Economics > Department of Statistics > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/45728)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.